会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 22. 发明申请
    • Easy-open dough packages and related methods of manufacture
    • 易开口面团包装及相关制造方法
    • US20060083909A1
    • 2006-04-20
    • US10968620
    • 2004-10-19
    • David MatthewsEric PlourdeBrian Daniels
    • David MatthewsEric PlourdeBrian Daniels
    • B31B45/00B65D85/00
    • B65D75/66B65B61/02B65D85/36Y10T428/249923
    • A generally tube-shaped package that has a tear strip joined to a web of packaging film, the tear strip incorporating an encapsulated tear notch. The package is filled with cookie or bread dough. In accordance with one embodiment, the tear strip is part of a tape that is joined to a web of packaging film. Preferably, the tear strip has a tear bead. Optionally, tearing off of the tear strip provides access to a peel seal, which in turn must be sundered to gain access to the dough. In accordance with another embodiment, the tear strip comprises a portion of a web of packaging film, which portion is bounded by a pair of mutually parallel capped tear lines. A tear bead is disposed between the tear lines. Methods of manufacturing such packages are disclosed.
    • 一种通常为管状的包装,其具有连接到包装膜的幅材的撕裂条,所述撕裂条包括封装的撕裂缺口。 包装充满了饼干或面包面团。 根据一个实施例,撕条是连接到包装薄膜网的带的一部分。 优选地,撕条具有泪珠。 任选地,撕裂撕条可以进入剥离密封件,剥离密封件又必须被清洗以便进入面团。 根据另一个实施例,撕条包括一部分包装膜的腹板,该部分由一对相互平行的覆盖撕裂线限定。 泪珠设置在撕裂线之间。 公开了制造这种包装的方法。
    • 28. 发明授权
    • Synergistic effects between sphingosine-1-phosphate receptor antagonists and antimicrotubule agents
    • 鞘氨醇-1-磷酸受体拮抗剂和抗微管剂之间的协同作用
    • US08802692B2
    • 2014-08-12
    • US13124586
    • 2009-10-16
    • Geetha ShankarFrauke BentzienPeter LambDavid Matthews
    • Geetha ShankarFrauke BentzienPeter LambDavid Matthews
    • A61K31/44A01N43/36A61K31/40
    • A61K31/4196A61K31/16A61K31/337A61K31/34A61K31/4192A61K31/435A61K2300/00
    • This invention is based on the discovery that the administration of a sphingosine-1-phosphate receptor antagonist (S1P) and at least one chemotherapeutic agent selected from the the group of antimicrotubule agents provides an unexpectedly superior treatment for cancer. Antimicrobial agents such as the taxane compounds are known in the art, for example, paclitaxel (available as TAXOL® from Bristol-Myers Squibb, Princeton, N.J.), docetaxel (available as TAXOTERE® from Sanofi-aventis, Bridgewater, N.J.) and the like and other compounds that act as antimicrotubule agents, such as Vincristine (ONCOVIN®, VINCASAR PFS®, VCR), Vinblastin (VELBAN®, VELSAR®) and Vinorelbine, and similar compounds. The present invention also provides methods of modulating the growth of selected cell populations, such as cancer cells, by administering a therapeutically effective amount of at least one sphingosine-1-phosphate 1 (S1P1R) receptor antagonists, and at least one antimicrotubule agent.
    • 本发明基于以下发现:施用鞘氨醇-1-磷酸受体拮抗剂(S1P)和选自抗微管剂组的至少一种化学治疗剂提供了对于癌症的意想不到的优异治疗。 抗菌剂如紫杉烷化合物是本领域已知的,例如紫杉醇(可从Bristol-Myers Squibb,Princeton,NJ获得),多西紫杉醇(可从Sanofi-aventis,Bridgewater,NJ获得)和 类似物和其它作为抗微管剂的化合物,如长春新碱(ONCVIN®,VINCASARPFS®,VCR),长春花碱(VELBAN®,VELSAR)和长春瑞滨等)和类似化合物。 本发明还提供了通过施用治疗有效量的至少一种鞘氨醇-1-磷酸1(S1P1R)受体拮抗剂和至少一种抗微管剂来调节所选细胞群体如癌细胞的生长的方法。